Rory B. Riggs - Jun 18, 2019 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Director
Signature
/s/ John P. Condon, Attorney-in-fact
Stock symbol
ITCI
Transactions as of
Jun 18, 2019
Transactions value $
$0
Form type
4
Date filed
10/15/2024, 06:00 PM
Next filing
May 11, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITCI Common Stock Options Exercise +14.2K +12.12% 131K Jun 18, 2019 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Restricted Stock Units Options Exercise $0 -14.2K -100% $0.00 0 Jun 18, 2019 Common Stock 14.2K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 On June 18, 2018, the reporting person was granted 14,189 restricted stock units, vesting on the first anniversary of the grant date (June 18, 2019).

Remarks:

This Form 4 is being filed to report the vesting on June 18, 2019 of previously reported restricted stock units. This transaction is being reported late due to an inadvertent administrative error.